Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorBAILLY, Thibaud
hal.structure.identifierInstitut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA]
dc.contributor.authorBODIN, Sacha
dc.contributor.authorGONCALVES, Victor
dc.contributor.authorDENAT, Franck
hal.structure.identifierInstitut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA]
dc.contributor.authorMORGAT, Clement
dc.contributor.authorPRIGNON, Aurelie
dc.contributor.authorVALVERDE, Ibai E
dc.date.accessioned2023-06-28T12:08:01Z
dc.date.available2023-06-28T12:08:01Z
dc.date.issued2023-05-11
dc.identifier.issn1948-5875en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/183228
dc.description.abstractEnBivalent ligands, i.e., molecules having two ligands covalently connected by a linker, have been gathering attention since the first description of their pharmacological potential in the early 80s. However, their synthesis, particularly of labeled heterobivalent ligands, can still be cumbersome and time-consuming. We herein report a straightforward procedure for the modular synthesis of labeled heterobivalent ligands (HBLs) using dual reactive 3,6-dichloro-1,2,4,5-tetrazine as a starting material and suitable partners for sequential SAr and inverse electron-demand Diels-Alder (IEDDA) reactions. This assembly method conducted in a stepwise or in a sequential one-pot manner provides quick access to multiple HBLs. A conjugate combining ligands toward the prostate-specific membrane antigen (PSMA) and the gastrin-releasing peptide receptor (GRPR) was radiolabeled, and its biological activity was assessed and (receptor binding affinity, biodistribution, imaging) as an illustration that the assembly methodology preserves the tumor targeting properties of the ligands.
dc.description.sponsorshipFrance Life Imaging - ANR-11-INBS-0006en_US
dc.language.isoENen_US
dc.subject.enBioconjugation
dc.subject.enClick chemistry
dc.subject.enDrug delivery
dc.subject.enHeterobivalent ligands
dc.subject.enRadiopharmaceuticals
dc.title.enModular One-Pot Strategy for the Synthesis of Heterobivalent Tracers
dc.title.alternativeACS Med Chem Letten_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1021/acsmedchemlett.3c00057en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed37197474en_US
bordeaux.journalACS Medicinal Chemistry Lettersen_US
bordeaux.page636-644en_US
bordeaux.volume14en_US
bordeaux.hal.laboratoriesInstitut de neurosciences cognitives et intégratives d'Aquitaine (INCIA) - UMR 5287en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.teamImagerie multimodale translationnelle
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.exportfalse
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=ACS%20Medicinal%20Chemistry%20Letters&rft.date=2023-05-11&rft.volume=14&rft.issue=5&rft.spage=636-644&rft.epage=636-644&rft.eissn=1948-5875&rft.issn=1948-5875&rft.au=BAILLY,%20Thibaud&BODIN,%20Sacha&GONCALVES,%20Victor&DENAT,%20Franck&MORGAT,%20Clement&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée